π₯ CPT +17003 β Destruction, Premalignant Lesions; 2nd Through 14th Lesion, Each (Add-On)
Quick Reference
wRVU: 0.18 (per unit) | Global Period: ZZZ (Add-On β inherits global of primary code 17000 / 010) | Assistant Payable: β No | Bilateral Indicator: 1 | Modifier-51 Exempt: β Yes β add-on code
Add-On Code β Never Bill Standalone
CPT +17003 is an AMA-designated add-on code. It requires CPT 17000 as the primary code on the same claim and same date of service. Billing 17003 without 17000 will result in an automatic claim denial. The + prefix in the AMA CPT manual designates this as an add-on code subject to NCCI add-on code edit enforcement.
π Clinical Description
CPT +17003 is an add-on code reported once for each additional premalignant lesion destroyed beyond the first, starting with the second lesion and continuing through β but not exceeding β the 14th lesion in a single session. The primary code 17000 covers the first lesion destroyed; +17003 is then stacked as individual units, one per additional lesion, up to a maximum of 13 units (covering lesions 2 through 14). Once the session reaches the 15th premalignant lesion, the entire 17000 + 17003 construct is abandoned and replaced by 17004 β the flat-rate code for 15 or more lesions β which is reported as a single unit in its place.
The destructive modality β cryosurgery, electrosurgery, laser surgery, chemosurgery, or surgical curettement β is the same as described under 17000; +17003 does not restrict or change the modality used. Actinic keratosis (AK) is the prototypical diagnosis driving this code, and all clinical parameters β lesion identification, UV etiology, malignant progression risk, and destruction technique β are identical to those described under the primary code. +17003 exists purely as a per-unit counting mechanism within the 2-14 lesion range and carries no independent clinical description beyond βeach additional lesion.β
This add-on code is reported in the following clinical contexts:
- Any session where 2-14 total premalignant lesions are destroyed β +17003 is required for every lesion beyond the first; a session treating 6 AKs requires 17000 + five units of +17003.
- Mixed anatomic site session within the 2-14 lesion range β AKs on the scalp, face, ears, and hands in the same session are counted collectively toward the total lesion count; each lesion adds one unit of +17003 after the first.
- Periocular and eyelid AK sessions (ophthalmology) β When an ophthalmologist treats multiple periocular AKs, +17003 stacks per lesion count in the same way; laterality and eyelid modifiers apply to the primary 17000 service for documentation; +17003 units are not individually modified by site.
- Re-treatment session for recurrent AKs in a high-risk patient β When a patient with prior skin cancer history returns for re-treatment of recurrent AKs and the count is 2-14, +17003 drives the additional per-lesion billing alongside 17000.
- Combined premalignant and benign destruction, total premalignant count 2-14 β When both AKs and benign lesions (seborrheic keratoses, verrucae) are destroyed in the same session, the premalignant count (2-14) drives 17000 + +17003, while the benign lesions are reported separately under 17110 or 17111 with modifier -59.
π¬ Anatomical & Procedural Considerations
| Modality | Mechanism / Steps | Key Notes |
|---|---|---|
| Cryotherapy (Liquid Nitrogen) | Liquid nitrogen spray or cotton-tip applicator applied to each lesion; freeze-thaw cycle destroys dysplastic keratinocytes | Most common modality; each lesion receiving cryo counts as one unit of +17003 after the first; the note must document the total lesion count β not just the modality |
| Electrosurgery / Electrodesiccation | High-frequency electrical current destroys lesion tissue via resistive heating; curettement may follow | Acceptable modality; the operative note must confirm tissue destruction in situ (not excision) β if the lesion is cut out, excision codes apply |
| Laser Surgery (COβ / Er:YAG) | Ablative laser vaporizes dysplastic epidermis at each AK site | Modality does not change the code; document laser type and each treated site; one unit of +17003 per additional lesion regardless of laser settings |
| Chemical Destruction | Provider-applied topical caustic agent (e.g., TCA) to each discrete lesion in-office | Patient self-applied field therapy agents (5-FU, imiquimod) are not reportable as 17003 β those are medication management encounters; in-office provider application qualifies |
| Surgical Curettement | Mechanical curettement of each dysplastic lesion with a dermal curette | Valid for premalignant lesions; confirm lesion is premalignant β curettement of malignant lesions maps to the malignant excision or destruction code families |
Clinical Pearl
The maximum units of +17003 per date of service is 13 β covering lesions 2 through 14. CMS has specifically identified excessive units of 17003 per date of service as a RAC audit recovery target; billing 14 or more units of 17003 in a single session (implying 15+ total lesions) when 17004 should have been reported instead is a recoverable overpayment. Before finalizing the claim, confirm: if total premalignant lesions treated = 14 or fewer β report 17000 + appropriate units of +17003. If total = 15 or more β report 17004 only. Count first, then code.
β Procedure Includes
- Destruction of each additional premalignant lesion (2nd through 14th) using the same modality documented under the primary 17000 service
- Routine wound care at each additional treatment site following destruction
- All pre-procedure assessment, patient preparation, and post-procedure instructions are included under the primary 17000 payment β +17003 does not separately bundle or unbundle these elements
- Documentation of individual lesion site and running count in the procedure note β essential for audit defense and unit justification
β Excludes / Do Not Report Together
| Code | Description | Relationship to +17003 |
|---|---|---|
| 17000 | Destruction, premalignant lesion; first lesion | Required primary code β +17003 cannot be reported without 17000 on the same claim; 17000 covers lesion #1; +17003 begins at lesion #2 |
| 17004 | Destruction, premalignant lesions; 15 or more lesions | Mutually exclusive in the same session β when the premalignant lesion count reaches 15, report only 17004; do NOT report 17000 + 17003 Γ 13 + 17004 together; 17004 replaces the entire stack |
| 17110 | Destruction, benign lesions other than skin tags or cutaneous vascular lesions; up to 14 lesions | Different lesion category β benign lesions are reported under 17110/17111, NOT 17000/17003; a NCCI edit exists; when both lesion types are treated in the same session, modifier -59 or XS is required to report both code families separately |
| 17311-17315 | Mohs micrographic surgery | When Mohs technique is used for any lesion in the session, the Mohs family replaces the destruction code for that specific lesion; remaining premalignant lesions destroyed by standard technique in the same session may still drive 17000 + +17003 if the count (excluding the Mohs lesion) is 2-14 |
| E/M codes (992xx / 920xx) | Office visit, any level | Separately reportable on the same date only when modifier -25 is appended to the E/M code; -25 is applied to the E/M code, never to +17003 or 17000 |
Add-On Code Rules β Global Period is ZZZ, Inherited from Primary 17000 (010)
The ZZZ global period assigned to +17003 is the AMA/CMS designation for add-on codes β it means this code has no independent global period and inherits the global period of its required primary code, 17000, which carries a 010 (10-day) global period. In practical billing terms: the 10-day global window is triggered by the 17000 service date, and all bundling rules (wound checks, related follow-up within 10 days) apply to the session as a whole β not to +17003 individually. Never attempt to assign an independent global period to +17003. For unrelated E/M visits within the 10-day global window, append modifier -24 to the E/M code with documentation of the unrelated nature β this is applied in the context of the 17000 global, not +17003 specifically.
π³ Code Tree β Surgery: Integumentary System, Destruction - Premalignant Lesions
CPT 17000-17004 Destruction β Premalignant Lesions
β
βββ 17000 Destruction, premalignant lesion; first lesion (Global: 010)
β βββ Primary code β required before +17003 can be reported
β
βββ βΆβΆ +17003 ββ Second through 14th lesion, each [Add-On] β YOU ARE HERE
β βββ Report 1 unit per additional lesion after the 1st
β βββ Maximum 13 units per date of service (covers lesions 2-14)
β βββ ALWAYS requires 17000 as primary on same claim, same DOS
β
βββ 17004 15 or more lesions (Global: 010)
βββ Replaces 17000 + +17003 entirely when count β₯ 15
CPT 17110-17111 Destruction β Benign Lesions (not skin tags or vascular)
βββ 17110 Up to 14 lesions (Global: 010)
βββ 17111 15 or more lesions (Global: 010)
π° RVU & Reimbursement Profile
| Component | Value |
|---|---|
| Work RVU (wRVU) | 0.18 per unit (verify against current CMS MPFS for applicable year) |
| Global Period | ZZZ β Add-On Code; inherits 010 (10-day) global from primary CPT 17000 |
| Bilateral Indicator | 1 β Inherits from primary service context; bilateral reduction is not applied to individual +17003 units in practice |
| Assistant Surgeon | β Not payable |
| Co-Surgeon | β Not applicable |
| Team Surgery | β Not applicable |
| PC/TC Split | β No β procedure code only (Indicator 0) |
| Modifier -51 Exempt | β Yes β add-on codes are modifier-51 exempt by AMA and CMS policy; do NOT append -51 to +17003 |
| Maximum Units Per DOS | 13 units β covers lesions 2 through 14; billing 14+ units implies a 15+ lesion session, which requires 17004 instead |
| Anesthesia | Included under primary 17000 payment; no separate anesthesia billing for +17003 units |
wRVU Stacking and Reimbursement Reality
Each unit of +17003 carries a wRVU of 0.18. When added to the 17000 base wRVU of 0.61, the maximum theoretical value of a full 17000 + 13 Γ 17003 session (14 total lesions) is approximately 0.61 + (13 Γ 0.18) = 2.95 wRVU β compared to 17004βs flat 1.30 wRVU for 15+ lesions. This means a session treating exactly 14 lesions reimbursed under 17000/17003 stacking pays significantly more per lesion than the 17004 flat rate. This is not a billing manipulation opportunity β it is the AMAβs intended payment design β but it underscores why accurate lesion counting is critical: undercounting a 15-lesion session as 14 to stay under 17004 constitutes fraudulent upcoding of the per-unit structure.
π·οΈ Modifier Reference
Add-On Code Modifier Rules
CPT +17003 is modifier-51 exempt and should not be reported with modifier -51 under any circumstance. Because +17003 is an add-on to 17000, it does not independently carry laterality, eyelid-site, or bilateral modifiers β those are applied to the primary 17000 service line when clinically appropriate. The modifiers below reflect how modifiers interact with the session as a whole rather than being appended to +17003 itself.
| Modifier | Applied To | When Applicable |
|---|---|---|
| -51 Exempt | +17003 itself | Add-on codes are exempt from -51 by AMA/CMS definition β never append -51 to +17003 |
| -25 | E/M code on same DOS | When a separately identifiable E/M service is performed on the same date as the AK destruction session; applied to the E/M code only β not to 17000 or +17003 |
| -24 | E/M code within 10-day global | When a patient returns within the 10-day global window of the primary 17000 for an unrelated condition; applied to the E/M code; document unrelated nature explicitly |
| -59 | 17110 or 17111 on same DOS | When benign lesion destruction is also performed in the same session; applied to the lower-valued benign destruction code to bypass the NCCI edit β not applied to +17003 |
| -XS | 17110 or [[17111]] on same DOS | MAC-preferred alternative to -59 for distinct lesion type documentation; same application context as -59 above |
| -52 | 17000 (primary) | When the destruction session is partially completed β applied to the primary code; +17003 units reflect only the lesions actually treated |
| -53 | 17000 (primary) | When the session is discontinued due to patient safety concern β applied to the primary code; document the count of lesions treated at time of discontinuation |
π©Ί Common ICD-10-CM Pairings
ICD-10-CM and Add-On Codes
Because +17003 is an add-on code that always accompanies 17000, the ICD-10-CM diagnosis codes reported with +17003 are identical to those reported with the primary 17000 service. The diagnosis code does not change per unit of +17003 β the same L57.0 (or applicable L57.- variant) applies to the entire session. The table below mirrors the 17000 pairing table; all diagnosis codes are reported on the same claim covering both 17000 and all units of +17003.
Primary β Actinic Keratosis and Premalignant Skin Changes
| ICD-10 Code | Description | HCC? | Clinical Notes |
|---|---|---|---|
| L57.0 | Actinic keratosis | β No | Primary diagnosis for the vast majority of 17000 + +17003 sessions; applies uniformly to the entire multi-lesion session β L57.0 is reported once on the claim, not once per lesion or per unit of +17003; no laterality or site-level specificity required at the ICD-10 code level |
| L57.1 | Actinic reticuloid | β No | Use when the dermatologist specifically documents actinic reticuloid rather than standard AK; uncommon; applies to the entire session |
| L57.8 | Other skin changes due to chronic exposure to nonionizing radiation | β No | Use for provider-documented UV-induced premalignant changes that do not meet the specific L57.0 AK descriptor β includes certain actinic injury patterns when the provider specifies |
| L57.9 | Skin changes due to chronic exposure to nonionizing radiation, unspecified | β No | Least specific in the L57 family; use only when documentation does not support a more specific L57.0-L57.8 code even after a provider query attempt |
Supporting / High-Risk Context Codes
| ICD-10 Code | Description | HCC? | Clinical Notes |
|---|---|---|---|
| Z85.828 | Personal history of other malignant neoplasm of skin | β No | Highly relevant secondary diagnosis for multi-lesion AK sessions β documents the elevated risk context (prior BCC, SCC, or melanoma) that supports medical necessity for treating multiple lesions in a single session; should be queried and captured when documented in the chart |
| Z77.098 | Contact with and (suspected) exposure to other hazardous, chiefly nonmedicinal, chemicals (UV) | β No | Applicable when chronic occupational or recreational UV exposure is explicitly documented as a contributing etiology; most useful for outdoor workers; supports medical necessity narrative |
| D04.9 | Carcinoma in situ of skin, unspecified | β No | Report when the provider documents in-situ squamous carcinoma (Bowen disease) among the lesions treated in the session; this is a premalignant/in-situ designation that remains within the 17000 family scope; when invasive malignancy is confirmed, shift that specific lesion to excision or Mohs codes |
Coding Specificity Reminder
ICD-10-CM code L57.0 requires no additional characters β it is a complete, non-extendable code with no laterality, site, or severity axis. For multi-lesion sessions using 17000 + +17003, report L57.0 once on the claim regardless of how many units of +17003 are billed. The number of lesions treated is a CPT documentation element, not an ICD-10-CM element. Do not attempt to report L57.0 multiple times or use different L57 codes for different lesions within the same session β the diagnosis applies to the encounter as a whole.
π₯ MS-DRG Considerations (Inpatient)
Inpatient Coding Reminder
CPT +17003 is an add-on code performed exclusively in the outpatient or office setting as part of the same service captured under primary CPT 17000. There are no MS-DRG assignments for this code β inpatient admission for premalignant skin lesion destruction is not clinically supported, and +17003 carries no independent inpatient facility coding equivalent. In the rare inpatient scenario where premalignant lesion destruction is performed, the ICD-10-PCS coding is driven by the primary destruction service β see the 17000 note for applicable PCS codes. There is no PCS add-on construct equivalent to the CPT +17003 per-unit model; each anatomic site treated is captured by its own PCS Destruction code line.
π§ ICD-10-PCS Equivalents (Inpatient Facility Coding)
Note
Because +17003 is an add-on code with no independent clinical identity, there is no distinct PCS code that maps specifically to β+17003β as a unit. Inpatient PCS coding for multi-lesion AK destruction mirrors the site-by-site Destruction (5) code structure used for the primary service β see CPT 17000 for the full PCS character analysis and code table. Each additional anatomic body part treated beyond the first requires its own PCS Destruction code line (e.g.,
0H51XZZfor face,0H52XZZfor right ear,0H50XZZfor scalp, etc.). The per-lesion counting mechanism of +17003 has no PCS equivalent β PCS codes by body part, not by lesion count within a body part.
| PCS Code | Full Description | Applicable Site |
|---|---|---|
0H50XZZ | Destruction of Scalp Skin, External Approach, No Device, No Qualifier | Additional AK lesions on the scalp beyond the first treated site |
0H51XZZ | Destruction of Face Skin, External Approach, No Device, No Qualifier | Additional facial AK lesions β cheek, forehead, nose, chin, temple |
0H52XZZ | Destruction of Right Ear Skin, External Approach, No Device, No Qualifier | Additional right auricular / periauricular lesions |
0H53XZZ | Destruction of Left Ear Skin, External Approach, No Device, No Qualifier | Additional left auricular / periauricular lesions |
0H54XZZ | Destruction of Right Upper Eyelid, External Approach, No Device, No Qualifier | Periocular AK β right upper eyelid |
0H55XZZ | Destruction of Left Upper Eyelid, External Approach, No Device, No Qualifier | Periocular AK β left upper eyelid |
PCS Coding for Multi-Lesion Sessions
- In ICD-10-PCS, assign one Destruction code per distinct body part value treated β not one code per lesion; PCS does not replicate the CPT per-unit counting structure of +17003.
- If the same body part (e.g., face skin, body part value 1) has multiple AK lesions destroyed, assign
0H51XZZonce β PCS does not allow multiple units of the same code for the same body part.- When multiple body parts are treated (scalp + face + right ear), assign separate PCS code lines for each body part; this is the closest ICD-10-PCS approximation of the multi-lesion CPT session.
π Coding Examples
Example 1 β Office: 6 AKs, Cryotherapy (17000 + 5 Units of +17003)
Clinical Scenario: A 65-year-old established male presents to dermatology for routine skin surveillance. The physician identifies and destroys 6 discrete actinic keratoses: 2 on the right cheek, 1 on the left cheek, 1 on the right temple, 1 on the forehead, and 1 on the right dorsal hand, all using liquid nitrogen cryotherapy. The procedure note reads: βCryotherapy to 6 AKs β sites as listed; single freeze-thaw cycle per lesion, 8-10 seconds each.β No separate E/M was documented beyond the pre-procedure assessment.
| Field | Code | Rationale |
|---|---|---|
| CPT 1 | 17000 | First premalignant lesion destroyed β required primary code for the session |
| CPT 2 | +17003 Γ 5 units | Lesions 2-6; 5 additional units of the add-on code β report as 5 units of 17003 on one line or as 5 separate lines per payer preference; -51 is NOT applied |
| PDx | L57.0 | Actinic keratosis β reported once for the session; applies to all 6 lesions |
| SDx | Z85.828 | Personal history of malignant neoplasm of skin β if documented; supports medical necessity for multi-lesion surveillance and treatment |
Note
+17003 is modifier-51 exempt β do not append -51 to the add-on code regardless of payer. When submitting electronically, most payers accept 17003 as a single line with 5 units in the quantity field; some payers prefer five individual line items at 1 unit each β verify your specific MAC and commercial payer preference before submitting. Never submit +17003 without 17000 on the same claim.
Example 2 β Office: 10 AKs + 12 Seborrheic Keratoses, Same Session, with Separate E/M
Clinical Scenario: A 71-year-old established female with a history of prior SCC of the scalp presents for a comprehensive skin clearance session. The dermatologist destroys 10 actinic keratoses (cryotherapy) and 12 seborrheic keratoses (electrodesiccation) in the same visit. The note clearly separates lesion types: β10 AKs treated with LN2 β [sites listed]; 12 SKs treated with electrodesiccation β [sites listed].β The physician also separately evaluates the patientβs new complaint of a pigmented lesion on the back, performs a dermoscopy evaluation, and documents independent history, exam, and assessment/plan for that separate concern.
| Field | Code | Rationale |
|---|---|---|
| CPT 1 | 17000 | First premalignant lesion (AK #1) β required primary code |
| CPT 2 | +17003 Γ 9 units | AK lesions 2-10; 9 units; -51 exempt; total premalignant count = 10, below 15-lesion threshold |
| CPT 3 | 17110-59 | 12 benign lesions (seborrheic keratoses); modifier -59 on the lower-valued code to bypass the NCCI edit between the premalignant (17000/17003) and benign (17110/17111) destruction families |
| CPT 4 | 99214-25 | Established patient E/M, moderate complexity; modifier -25 on the E/M code for the separately documented dermoscopy/pigmented lesion evaluation; NOT applied to 17000 or +17003 |
| PDx | L57.0 | Actinic keratosis β primary diagnosis driving 17000 + +17003 |
| SDx | L82.1 | Other seborrheic keratosis β diagnosis supporting 17110 |
| SDx | Z85.828 | Personal history of malignant neoplasm of skin (prior scalp SCC) |
Warning
Three separate billing actions are occurring here: (1) premalignant destruction via 17000 + +17003, (2) benign destruction via 17110 with -59, and (3) a separately identifiable E/M with -25. The -25 goes on the E/M code only, -59 goes on the 17110 only, and +17003 takes no modifier. Misplacing -59 on +17003 or -25 on 17000 are the two most common modifier placement errors in this multi-code scenario.
Example 3 β Office: 14 AKs β Maximum +17003 Units; vs. 15 AKs β Switch to 17004
Clinical Scenario A (14 lesions): A 76-year-old male presents for AK clearance. The physician documents and destroys exactly 14 actinic keratoses with cryotherapy. The note enumerates each lesion site with a running count ending at 14.
| Field | Code | Rationale |
|---|---|---|
| CPT 1 | 17000 | First lesion |
| CPT 2 | +17003 Γ 13 units | Lesions 2-14; 13 units β the maximum allowable per date of service; total session = 14 lesions |
| PDx | L57.0 | Actinic keratosis |
Clinical Scenario B (15 lesions β same scenario with one more lesion found and treated): During the same type of visit, the physician finds and destroys one additional AK, bringing the total to 15.
| Field | Code | Rationale |
|---|---|---|
| CPT 1 | 17004 | 15 premalignant lesions β flat-rate code replaces the entire 17000 + +17003 stack; report only 17004, 1 unit |
| PDx | L57.0 | Actinic keratosis |
Note
The 15-lesion threshold is a hard switch. There is no version of a 15-lesion session that is correctly coded as 17000 + 17003 Γ 13 + any additional code. Once lesion #15 is documented and treated, only 17004 is reported and the 17000/17003 structure is abandoned entirely. CMS RAC auditors specifically flag claims with 13+ units of 17003 in a session because it may indicate the threshold was reached and 17004 should have been used instead. Count before you code.
β οΈ Common Coding Pitfalls
-
Billing +17003 without 17000 on the same claim: +17003 is an add-on code β it has no standalone billing value and will be automatically denied by every payer if submitted without 17000 as the primary code on the same date of service. This is the most fundamental rule of add-on code billing and the most common cause of clean-claim failure for this code. Verify that your billing system always triggers 17000 when +17003 is entered.
-
Appending modifier -51 to +17003: Add-on codes are modifier -51 exempt by AMA and CMS policy β they are defined as services that cannot stand alone and do not require -51 to identify them as secondary procedures. Appending -51 to +17003 is technically incorrect and may trigger a claim edit or payment reduction at some payers. Do not add -51 to any add-on code.
-
Billing more than 13 units of +17003 per date of service: The maximum is 13 units (covering lesions 2-14). If 14 or more units of +17003 appear on a claim, it implies 15 or more total lesions were treated β and 17004 should have been reported instead. CMS RAC guidance explicitly identifies excessive units of 17003 as a recovery target. A claim showing 17000 + 17003 Γ 14 units is an automatic overpayment flag.
-
Counting lesion type incorrectly β mixing benign and premalignant in the +17003 unit count: Only premalignant lesions are counted toward the 17000/17003/17004 family. Benign lesions (seborrheic keratoses, warts) are reported under the 17110/17111 family. If a provider destroys 8 AKs and 6 SKs and the biller counts all 14 as one group, the resulting 17000 + +17003 Γ 13 represents a significant upcoding violation. The procedure note must clearly separate lesion types by count, and the coder must bill each family independently.
-
Misplacing modifier -25 on 17000 or +17003 instead of the E/M code: Modifier -25 belongs exclusively on the E/M service code when a separately identifiable office visit is billed on the same date as AK destruction. Appending -25 to 17000 or +17003 is a modifier placement error that will generate a claim edit and is a compliance finding in dermatology practice audits. Train billing staff on this distinction specifically.
-
Failing to document a per-lesion enumeration in the procedure note: βSeveral AKs treatedβ or βmultiple lesions, cryotherapyβ without a specific count does not support any specific number of +17003 units on audit. Each unit of +17003 represents one billable lesion β if the count is not documented in the procedure note, payers will default to 17000 alone (1 lesion) regardless of how many units of +17003 were billed. The note must state a specific number: βcryotherapy to 8 AKs β [sites].β
π Sources
1 AMA CPT 2025 Professional Edition β CPT +17003, Surgery: Integumentary System, Destruction-Premalignant Lesions; add-on code designation and reporting instructions Β· 2 CMS 2025 Medicare Physician Fee Schedule Final Rule (CMS-1807-F) Β· 3 CMS RVU25A Relative Value Files β wRVU (0.18 per unit), ZZZ global period, and bilateral indicator data for CPT +17003 Β· 4 CMS Medicare NCCI Add-On Code Edits Policy β cms.gov/medicare/coding-billing/national-correct-coding-initiative-ncci-edits/medicare-ncci-add-code-edits Β· 5 CMS Medicare RAC Guidance 0121 β Destruction of Premalignant Lesions: Excessive Units; CPT 17000/17003/17004 maximum units per date of service Β· 6 NCCI Policy Manual Chapter 4 (Surgery: Integumentary System), CMS 2025 β bundling rules between premalignant (17000/17003/17004) and benign (17110/17111) destruction families; modifier -59/XS guidance Β· 7 ICD-10-CM Official Guidelines for Coding and Reporting FY2026 β Chapter 12: Diseases of the Skin and Subcutaneous Tissue, L57 coding guidance Β· 8 ICD-10-PCS Official Guidelines for Coding and Reporting FY2026 β Root Operation Destruction (5), Body System H (Skin and Breast) Β· 9 AAPC CPT Code 17003 Reference β aapc.com/codes/cpt-codes/17003 Β· 10 Auctus Group Consulting β βCPT Code 17003: Everything You Need to Knowβ (2025) Β· 11 AultCare β βUnderstanding Add-On Procedure Code Denialsβ (2024) Β· 12 Palmetto GBA Jurisdiction M β Global Period and Modifier Policy (2024) Β· 13 AAPC Dermatology Coding Alert β Premalignant Lesion Destruction Series 17000/17003/17004 Coding Guidelines
Crystal's Coder Hub